Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: Neutrophil-to-lymphocyte ratio as an exacerbation marker
International Journal of COPD Dec 01, 2017
Acartürk Tunçay E, et al. - Researchers sought to determine the utility of neutrophil-to-lymphocyte ratio (NLR) as an infectious exacerbation marker in patients with chronic respiratory failure (CRF) ascribed to COPD. Since NLR displayed simplicity and cost-effectiveness, it was considered as an attractive option as an exacerbation marker in COPD patients with CRF. In addition, considering antibiotic treatment was recommended in this group of patients with NLR ≥3.54, peripheral eosinophilia levels <2%, and subjective symptoms.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries